These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28787005)

  • 21. Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.
    Zhou Z; Xiao L; Branch OH; Kariuki S; Nahlen BL; Lal AA
    Am J Trop Med Hyg; 2002 Jan; 66(1):7-12. PubMed ID: 12135271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India.
    Kaur H; Sehgal R; Goyal K; Makkar N; Yadav R; Bharti PK; Singh N; Sarmah NP; Mohapatra PK; Mahanta J; Bansal D; Sultan AA; Kanwar JR
    Trop Med Int Health; 2017 Dec; 22(12):1590-1598. PubMed ID: 29029367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
    Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
    Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
    Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
    Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India.
    Joshi H; Valecha N; Verma A; Kaul A; Mallick PK; Shalini S; Prajapati SK; Sharma SK; Dev V; Biswas S; Nanda N; Malhotra MS; Subbarao SK; Dash AP
    Malar J; 2007 May; 6():60. PubMed ID: 17517129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for antibody recognition of the NANP repeats in
    Oyen D; Torres JL; Wille-Reece U; Ockenhouse CF; Emerling D; Glanville J; Volkmuth W; Flores-Garcia Y; Zavala F; Ward AB; King CR; Wilson IA
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10438-E10445. PubMed ID: 29138320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium falciparum: worldwide sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-2 (MSP-2).
    Ferreira MU; Hartl DL
    Exp Parasitol; 2007 Jan; 115(1):32-40. PubMed ID: 16797008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity of Plasmodium falciparum isolates from concurrent malaria and arbovirus co-infections in Kedougou, southeastern Senegal.
    Niang M; Loucoubar C; Sow A; Diagne MM; Faye O; Faye O; Diallo M; Toure-Balde A; Sall AA
    Malar J; 2016 Mar; 15():155. PubMed ID: 26969623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism and amino acid sequence variation in Plasmodium falciparum GLURP R2 repeat region in Assam, India, at an interval of five years.
    Kumar D; Dhiman S; Rabha B; Goswami D; Deka M; Singh L; Baruah I; Veer V
    Malar J; 2014 Nov; 13():450. PubMed ID: 25416405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.
    Khan F; Porter M; Schwenk R; DeBot M; Saudan P; Dutta S
    PLoS One; 2015; 10(11):e0142035. PubMed ID: 26571021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
    Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
    Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda.
    Agwang C; Erume J; Okech B; Olobo J; Egwang TG
    Malar J; 2020 Oct; 19(1):361. PubMed ID: 33032613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-dependent antibody response to Plasmodium falciparum merozoite surface protein 2 (MSP-2).
    Khosravi A; Hommel M; Sayemiri K
    Parasite Immunol; 2011 Mar; 33(3):145-57. PubMed ID: 21306398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens.
    Boudová S; Walldorf JA; Bailey JA; Divala T; Mungwira R; Mawindo P; Pablo J; Jasinskas A; Nakajima R; Ouattara A; Adams M; Felgner PL; Plowe CV; Travassos MA; Laufer MK
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28835359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.